NCT07874048Not yet recruiting
CENTAURI Post-Market Clinical Registry
Source: ClinicalTrials.gov · Last updated 14 Oct 2026
Brief summary (registry, in English)
The objective of this post-market clinical registry is to collect realworld clinical experience across multiple European centers regarding the safety and efficacy of the CENTAURI System
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 8 Oct 2026
- Start date
- Dec 2026
- Primary completion date
- Dec 2029
- Lead sponsor
- CardioFocus
- Diseases
- Atrial fibrillation
- NCT number
- NCT07874048
What you commit to
- Study type: Observational
- Planned participants: 300
- From Dec 2026 to the primary completion date, Dec 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients who have had an atriotomy within the preceding eight weeks as the recent surgery may increase the risk of perforation
- Patients with a prosthetic heart valve, in which the catheter may pass through, as the catheter may damage the prosthesis
- Patients with active systemic infection, as this may increase the risk for cardiac infection
Other
- Patients with an atrial myxoma or intracardiac thrombus as the catheter could precipitate an embolus
- Patients with an interatrial baffle or patch as the opening could persist and produce an iatrogenic atrial shunt
- In patients who have vena cava embolic protection filter devices and/or known femoral thrombus who require catheter insertion from the femoral approach
- In patients who are hemodynamically unstable, as per physician discretion
Who the study is looking for
- Patients diagnosed with paroxysmal AF and indicated for an ablation procedure according to society guidelines or participating site practice
- Age ≥18 years of age
- Patient is willing and able to provide written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.